Melissa Haussman

Reproductive Rights and the State

Getting the Birth Control, Ru-486, and Morning-After Pills and the Gardasil Vaccine to the U.S. Market

• Broschiertes Buch

Produktbeschreibung

Simultaneously examining four significant, never-before-combined case studies, this unique feminist analysis offers troubling revelations about the private-public interaction in U.S. policy affecting birth control drugs. Reproductive Rights and the State: Getting the Birth Control, RU-486, and Morning-After Pills and the Gardasil Vaccine to the U.S. Market tackles a subject that remains controversial more than 60 years after "the pill" was approved for use in the United States. The first book to examine the politicization of the FDA approval process for reproductive drugs, this study maps the hard-fought battles over the four major drugs currently on the U.S. market. To make her case, Melissa Haussman scrutinizes the history of the FDA and the statutes that have governed it, as well as interactions between the U.S. government, American pharmaceutical companies, and the medical community. The analysis centers on explaining how three reproductive drugs were kept off the U.S. market well after their efficacy had been proven, while the availability of the fourth, Gardasil, has less to do with helping girls than with preserving the financial wellbeing of Merck. Readers will come away understanding how, when it comes to reproductive drugs, women's health concerns have consistently taken a backseat to political agendas and corporate profits.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Praeger
• Seitenzahl: 200
• Erscheinungstermin: 1. Januar 2013
• Englisch
• Abmessung: 234mm x 156mm x 11mm
• Gewicht: 313g
• ISBN-13: 9780313398223
• ISBN-10: 0313398224
• Artikelnr.: 34553604

Autorenporträt

MELISSA HAUSSMAN is Associate Professor of Political Science at Carleton University, Ottawa, Canada. She is the author of Abortion Politics in North America (2005).

Inhaltsangabe

Series Foreword Acknowledgments 1 Introduction 2 History of the FDA and
Drug Regulation in the United States 3 The Development of the Pill 4 U.S.
Pro-Choice and Pro-Life Groups' Strategies since 1960 5 Problems with
Mifepristone (RU-486) and Misoprostol (Cytotec), 1988-2000 6 The
"Morning-After Pill," Plan B (Levonorgestrel) Formulation 7 Reverse
Lobbying for Gardasil 8 Conclusion: Why a Feminist Historical
Institutionalist Lens Is Important Selected Bibliography Index